Documents
Cat#: VRS-0124-YT5192
Bac-SARS-CoV-2 S Pseudovirus
SARS-CoV-2 spike pseudovirus is generated by co-transfection 293T cells with a modified baculovirus vector, a fluorescent protein vector and a plasmid encoding SARS-CoV-2 S protein. The supernatants were harvested at 64 hours post transfection. The supernatants are centrifuged to remove cell debris, concentrated and passed through filter to get pseudovirus. The pseudovirus express SARS-CoV-2 spike protein on the surface, and also a fluorescent reporter which can be used to evaluate the SARS-CoV-2 infection when co-culture with human ACE2-overexpressed pseudohost. Pseudoviruses are useful virological tools because of their safety and versatility.
Made to Order Requirements
Your choose infomation:
CLEAR(Note: Please select the requirements to fit you project. If you have any other requirements, please specify. If no specific requirements, you don't need to select any button.)
- Product Summary
- Packaging, Storage & Formulations
- Target Details
Product Summary
| Type : | Pseudovirus |
| Virus Name : | Severe Acute Respiratory Syndrome Coronavirus 2 |
| Virus Packaging Protein : | S |
| Packaging System : | Baculovirus Packaging System |
| Packaging Cell : | 293T |
| Titer : | >1x 108 virus copies/mL |
| Application Notes : | The pseudovirus can be usd for the following applications: 1. Antibody neutralization assay, Serum neutralization assay. 2. As virus standard alternative in diagnostic assay or others. 3. Drug screening including vaccine development, viral entry inhibitor development. 4. As a safe virology tool to discover the virus entry mechanisms. |
Packaging, Storage & Formulations
| Form : | Liquid |
| Storage : | Store at -80°C and stable for 1 year from the date of shipment, avoiding freeze/thaw cycles. |
| Shipping : | Dry ice |
| Note : | The pseudovirus can be used under BSL-1 conditions. Please reach out to our scientists for detailed instructions or guidelines of the pseudovirus. |
Target Details
| Introduction : | An outbreak of a novel coronavirus disease (COVID-19; previously known as 2019-nCoV) was reported since last December, 2019. Now COVID-19 is an emerging, rapidly evolving situation, and has become a pandemic.SARS-CoV-2 consists of four structural proteins, including S (spike), E (envelope), M (membrane), and N (nucleocapsid) proteins. As an important envelope protein, S protein is identified as the protein responsible for virus entry into human cells, and S protein is the major target for anti-SARS-CoV-2 therapeutics discovery. |
| Alternative Names : | SARS-CoV-2, 2019nCoV, COVID-19, S, Spike, Pseudovirus, Spike Pseudovirus, S Pseudovirus, SARS-CoV-2 Spike Pseudovirus, SARS-CoV-2 S Pseudovirus, COVID-19 Spike Pseudovirus, COVID-19 S Pseudovirus |
| Gene ID : | 43740568 |
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
pepFastX™ Platform
If no antibody is available for your research, we recommend our novel pepFastX™ antibody discovery platform. The mAb products can be delivered within 2-3 months.
Learn more
We're here to help
Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.
Contact tech support